Evaluating and reporting persons under investigation (PUI)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Evaluating and reporting persons under investigation (PUI)
Filetype[PDF-70.18 KB]


Details:
  • Description:
    Updated February 27, 2020 Limited information is available to characterize the spectrum of clinical illness associated with 2019-nCoV. No vaccine or specific treatment for 2019-nCoV infection is available; care is supportive. The CDC clinical criteria for a 2019-nCoV person under investigation (PUI) have been developed based on what is known about MERS-CoV and SARS-CoV and are subject to change as additional information becomes available. Health care providers should obtain a detailed travel history for patients being evaluated with fever and acute respiratory illness. CDC guidance for evaluating and reporting a PUI for MERS-CoV remains unchanged. On February 11, 2020 the World Health Organization announced an official name for the disease that is causing the 2019 novel coronavirus outbreak, COVID-19. CDC will be updating our website and other CDC materials to reflect the updated name.
  • Content Notes:
    Criteria to Guide Evaluation of PUI for COVID-19 -- International Areas with Sustained (Ongoing) Transmission (Updated February 28, 2020) -- Recommendations for Reporting, Testing, and Specimen Collection (Updated February 28, 2020) -- Footnotes.
  • Document Type:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: